ABT-199 10 mg | ≥98% LKT Laboratories, Inc. BH3 mimetic; Bcl-2 inhibitor. More Information Supplier Page × ABT-199
ABT-199 5 mg | ≥98% LKT Laboratories, Inc. BH3 mimetic; Bcl-2 inhibitor. More Information Supplier Page × ABT-199
ABT-199 5 mg | ≥98% LKT Laboratories, Inc. BH3 mimetic; Bcl-2 inhibitor. More Information Supplier Page × ABT-199
AZD-1208 1 mg | ≥98% LKT Laboratories, Inc. Pim-1 inhibitor. More Information Supplier Page × AZD-1208
GSK-343 1 mg | ≥98% LKT Laboratories, Inc. EZH2 HMT inhibitor. More Information Supplier Page × GSK-343
INCB-28060 10 mg | ≥98% LKT Laboratories, Inc. c-MET inhibitor. More Information Supplier Page × INCB-28060
INCB-28060 5 mg | ≥98% LKT Laboratories, Inc. c-MET inhibitor. More Information Supplier Page × INCB-28060
INCB-28060 1 mg | ≥98% LKT Laboratories, Inc. c-MET inhibitor. More Information Supplier Page × INCB-28060
